0001683168-24-007114.txt : 20241015 0001683168-24-007114.hdr.sgml : 20241015 20241011174456 ACCESSION NUMBER: 0001683168-24-007114 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241015 DATE AS OF CHANGE: 20241011 EFFECTIVENESS DATE: 20241015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Model Medicines, Inc. CENTRAL INDEX KEY: 0001892786 ORGANIZATION NAME: IRS NUMBER: 844343971 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-526663 FILM NUMBER: 241368596 BUSINESS ADDRESS: STREET 1: 1268 PROSPECT STREET CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 732-423-2763 MAIL ADDRESS: STREET 1: 1268 PROSPECT STREET CITY: LA JOLLA STATE: CA ZIP: 92037 D 1 primary_doc.xml X0708 D LIVE 0001892786 Model Medicines, Inc. 1268 PROSPECT STREET LA JOLLA CA CALIFORNIA 92037 858-750-1298 DELAWARE Repurpose.AI, Inc. None Corporation true Daniel Haders 1268 Prospect Street La Jolla CA CALIFORNIA 92037 Executive Officer Director Marlon Evans 1268 Prospect Street La Jolla CA CALIFORNIA 92037 Executive Officer Director Kip Quackenbush 1268 Prospect Street La Jolla CA CALIFORNIA 92037 Executive Officer Director Biotechnology Decline to Disclose 06b false 2024-09-26 false true false 0 Indefinite 14754032 Indefinite false 43 0 0 0 false Model Medicines, Inc. /s/ Daniel Haders Daniel Haders Chief Executive Officer 2024-10-11